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Background: Postoperative pneumonia following resection of bronchogenic carcinoma is a severe
complicationwithahigh rate ofmorbidity andmortality. Theobjectiveof this study is to determine
the clinical and epidemiologic characteristics and the risk factors of postoperative pneumonia in
patients undergoing resection of bronchogenic carcinoma in a third-level university hospital.
Methods: We performed a study of cases (with postoperative pneumonia) and controls (without
pneumonia) nested in aprospective cohort of 604patientswhohadundergone surgery for broncho-
genic carcinoma in clinical stages IeIIIa betweenJanuary 1999and June2004,whereeachcasewas
grouped with 3 controls (3:1) of the same age (5 years) and cancer staging bymeans of TNM clas-
sification.
Results: The incidence of postoperative pneumonia was 22 cases (3.6%). Overall in-hospital
mortality of patients who underwent resection of bronchogenic carcinoma was 32 patients
(5.3%). In-hospital mortality due to postoperative pneumonia was 7 cases (31.8%). In theommittee on Cancer; APACHE, Acute Physiology and Chronic Health Evaluation; ARDS, acute respi-
n Thoracic Society; AUC, area under the curve; BMI, body mass index; BUN, blood urea nitrogen; CEA,
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fusion lung capacity for carbon monoxide; ECOG, Eastern Cooperative Oncology Group; FEV1, forced
ICU, intensive care unit; IDSA, Infectious Disease Society of America; OR, odds ratio; PCA, patient-
pathogenic microorganisms; PPP, predicted postoperative product; ROC, receiver-operating-char-
ion and mechanical ventilation; TNM, tumor-lymphatic nodes-metastasis; VAP, ventilator-associated
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1464 V. Dı´az-Ravetllat et al.postoperative pneumonia group, microorganisms were isolated in 10 cases (45.5%). The following
factors appear in the multivariate analysis as statistically significant independent risk factors for
postoperative pneumonia: body mass index <26.5 kg/m2 (adjusted odds-ratio (OR) per unit
0.64, 95%confidence interval (CI) 0.45e0.90,pZ0.011), predictedpostoperativeFEV1<50%pred.
(adj. OR per unit 0.92, 95% CI 0.85e0.99, pZ 0.037), and reintubation after surgery (adj. OR 18.1,
95% CI 1.3e256.6, pZ 0.032).
Conclusions: Identifying the risk factors (some of which can by modified by medical intervention)
may improve the course of lung cancer treated with surgery.
ª 2012 Elsevier Ltd. All rights reserved.Introduction
Surgical resection is the best therapeutic option for patients
with bronchogenic carcinoma, and is the treatment of
choice in the initial stages, as it provides the best probability
of a cure.1 Nevertheless, this treatment is subject to
complications. The general incidence of postoperative
complications after thoracic surgery is approximately 30%.2
Postoperative respiratory complications are the most
frequent and the most common cause of mortality after
lung resection.1,3,4 The incidence of postoperative pneu-
monia ranges between 2% and 20%.1,5,6 Despite advances in
surgical techniques, anesthesia, and the perioperative
period, nosocomial pneumonia is one of the principal cau-
ses of postoperative mortality,7e9 especially severe after
thoracic surgery,5,8,9 ranging between 22% and 67%.6,10,11
Several risk factors for postoperative pneumonia have
been published, including advanced age, male sex,12
smoking,2 poor nutrition, chronic obstructive pulmonary
disease (COPD), preoperative deterioration of lung function,
prolonged duration of surgery and surgical stress, extent of
the resection (pneumonectomy), surgery on the right side,2
and postoperative mechanical ventilation.1,2,4,6e9,11e16
Potentially pathogenic microorganisms (PPM) are usually
responsible for respiratory infections, regardless they
belong to the oropharyngeal or gastrointestinal flora. The
PPM usually associated with nosocomial pneumonia are
Staphylococcus aureus, Pseudomonas aeruginosa, Enter-
obacteriaceae, and other non-fermenting gram-negative
bacilli (such as Stenotrophomonas maltophilia).9 Post-
operative pneumonia prolongs the length of stay in hospital
and increases the use of resources.4,8
For these reasons, there is growing interest in identi-
fying the factors associated with risk, prevention, diagnosis
and treatment of respiratory infections after resection of
lung cancers. The objective of this study was to determine
the clinical and epidemiologic characteristics and the risk
factors of postoperative pneumonia after resection of
bronchogenic carcinoma in a third-level university hospital.
Materials and methods
Patients
The study was approved by the Ethics Committee of our
institution (Comite` E`tic d’Investigacio´ Clı´nica, registration
number 2010/6159).This study was conducted in the Thoracic Surgery
Department of Hospital Clı´nic, Barcelona, Spain, a tertiary
university hospital. Patients who had undergone resection
of bronchogenic carcinoma in clinical stages IeIIIa were
prospectively followed for 5 years, between January 1999
and June 2004. We identified all consecutive cases with
postoperative pneumonia and matched them with 3
patients without pneumonia in a nested case-control study.
The matching criteria were age (5 years) and cancer
staging by means of pathological TNM classification.
Exclusion criteria were a diagnosis of respiratory infec-
tion in the previous 30 days, antibiotic treatment for any
reason in the 4 weeks prior to the current admission,
hospital admission in the previous 3 months due to respi-
ratory problems, severe immunosuppression, treatment
with corticosteroids (>20 mg of prednisone/d) and/or
emergency thoracic surgery.
Intravenous cefazolin (2 g) was administered preopera-
tively for wound infection prophylaxis in 76 patients (90.5%)
while amoxicillin-clavulanic (1 g) was administered in 8
patients (9.5%). Another dose was administered the next
day and also during the procedure if surgery lasted more
than 4 h. If the patient had been allergic to penicillin,
vancomycin or clindamycin had been dispensed.
Posterolateral thoracotomy was performed in all
patients. Management of postoperative pain included
epidural anesthesia with ropivacaine combined with fen-
tanyl using a patient-controlled analgesia (PCA) pump
during 2 or 3 days and bolus of methadone prior to with-
drawal of the catheter. The chest drain policy was to
remove it when there was no air leak and the debit was less
than 200 cc in 24 h.
Pneumonectomy patients who were in the anesthetic
recovery room or intensive care unit (ICU) were extubated
when they were stable, conscious and tolerated a sponta-
neous breathing trial.
We proceeded, as previously described by our group, to
reintubation if any of the following clinical events arose:
respiratory or cardiac arrest; respiratory pauses with loss of
consciousness or gasping for air; psychomotor agitation
inadequately controlled by sedation; massive aspiration;
persistent inability to remove respiratory secretions; heart
rate below 50 beats per min with loss of alertness; and
severe hemodynamic instability without response to fluids
and vasoactive drugs. Additional criteria were respiratory
failure with deterioration of blood gases (arterial pH,
PaCO2, PaO2.) or tachypnea despite use of non-invasive
ventilation for 4 h.17
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The clinical diagnosis of pneumonia was based on the
presence of new or progressive lung infiltrates and 2 or
more of the following criteria: body temperature <36 C or
>38 C, leukocyte count <4000 or >12,000 cells/mm3, and/
or purulent tracheobronchial secretions18; or based on
a clinical pulmonary infectious score (CPIS) 6.19 CPIS was
calculated in patients with ventilator-associated pneu-
monia (VAP).
Postoperative pneumonia was defined as pneumonia
diagnosed in the first 30 days after the operation or before
discharge from hospital.
All patients included were diagnosed with unilateral
infiltrates; there were not observed bilateral infiltrates.
Acute lung injury was rejected as a possible diagnosis
because lung infiltrates were not bilateral.
The microbiologic study included obtaining at least 1
sample from the lower airway by means of sputum,
tracheobronchial aspiration, bronchial brushing using
a telescopic catheter, bronchoscopy, or bronchoalveolar
lavage, where possible, within 24 h of inclusion in the
study. The same sampling method was used after 3 days if
clinically indicated. Blood samples were also taken in all
patients included in the study.
Microbiologic confirmation of pneumonia was defined as
the presence of at least 1 PPM in the aforementioned
respiratory samples, within the following thresholds:
>103 colony forming units (CFU)/mL in bronchial brushing
with a telescopic catheter, >104 CFU/mL in bron-
choalveolar lavage, and/or >105 CFU/mL in sputum or
tracheobronchial aspirate, respectively. Microbe identifi-
cation and the antibiotic susceptibility test were performed
using standard methods.20 Polymicrobial pneumonia was
defined when more than 1 PPM was identified as a causative
agent.
Early nosocomial pneumonia was defined when diag-
nosed within the first 4 days of hospitalization whereas late
pneumonia, at 5 days or more.21,22
Initial empirical antibiotic treatment was administered
in accordance with the local adaptation of the guidelines of
the American Thoracic Society (ATS)/Infectious Disease
Society of America (IDSA),22 based on the most frequently
isolated PPM and their antimicrobial sensitivity patterns in
our institution, and subsequently revised depending on the
microbiology results.
Septic shock was defined as hypotension due to sepsis
that persisted despite appropriate fluid intake, together
with abnormalities due to hypoperfusion.23
Postoperative in-hospital mortality was defined as death
during the hospitalization period.15,16
For disease staging, the study used the TNM classifica-
tion published in 2009 by the American Joint Committee on
Cancer (AJCC), whereas the Eastern Cooperative Oncology
Group (ECOG)14 scale was used to determine clinical stage.
The predicted postoperative product (PPP) is a variable,
described by Pierce et al., obtained by multiplying the
predicted postoperative FEV1 with predicted postoperative
DLCO (both calculated from the quantified perfusion gam-
magraphy), both expressed as a percentage of the value of
reference.Data collection
The collected data were taken from the medical records of
patients, and included biographic data, anthropometric
data, personal history and history of disease, hospital
management, functional and anesthesia data, data on
diagnosed tumors, postoperative data, and data relating to
postoperative pneumonia (Annex 1).
Statistical analysis
A total sample size of 88 patients (22 patients in pneumonia
arm and 66 patients in non-pneumonia arm, according to
1:3 allocation ratio) was estimated to provide at least a 80%
power and a two-sided alpha value of 0.05 to detect as
statistically significant a difference of 35% in the
percentage of patients reintubated between groups (40%
pneumonia vs. 5% non-pneumonia).
The data are presented in numbers (percentages) and
mean (SD). The continuous variables were compared using
the t-test or the ManneWhitney U-test where appropriate.
Categorical variables were compared using the Chi-square
test or the Fisher exact test, when appropriate. Univariate
and multivariate logistic regression analyses were performed
to identify variables associated with postoperative pneu-
monia (dependent variable). We performed multivariate
analyses by logistic regression with a conditional stepwise
forward model (pin < 0.10). Variables highly correlated were
excluded from multivariate analyses. The predictive
capacity for postoperative pneumonia of continuous vari-
ables was assessed with receiver-operating-characteristics
(ROC) curves; the area under the curve (AUC), optimal
cut-off values, sensitivity, specificity, positive likelihood
ratio (PLR) and negative likelihood ratio (NLR) were calcu-
lated. All tests were two-tailed and significance was set as
5%. All the data were analyzed using the SPSS statistical
software package, version 19, from IBM.
Results
Patients
During the study period 2260 patients were admitted to the
Thoracic Surgery Department of our center. Of 1623
thoracic-surgery operations performed in this period, 604
corresponded to resection of lung carcinoma in clinical
stages IeIIIa and were prospectively followed.
There were 2 patients in the pneumonia group and 2 in
the non-pneumonia group who received chemotherapy
because of another previous registered carcinomas
(adrenal, pulmonary, cerebral, and unknown origin carci-
noma). This was not real neoadjuvant chemotherapy
because the reason for its use was not the neoadjuvant for
our study period lung cancer resection. On the other hand,
the blood analysis of all included patients showed no
changes suggestive of impaired immunity.
The incidence of postoperative pneumonia was 22 cases
(3.6%). Overall in-hospital mortality of the patients who
underwent resection of bronchogenic carcinoma was 32
patients (5.3%).
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operative pneumonia (except in 4 cases, where it was only
possible to group 2 controls with each case). A total of 84
adult patients were evaluated (22 cases with postoperative
pneumonia and 62 controls).
Of all the variables studied, those that showed statisti-
cally significant differences (p < 0.05) between the pneu-
monia and the non-pneumonia groups were the following:
weight, body mass index (BMI), heart failure (Table 1),
blood urea nitrogen (BUN), carcinoembryonic antigen
(CEA), TNM and clinical stage (non-pathological), preoper-
ative FEV1/FVC index, forced expiratory volume in the first
second (FEV1) and diffusion lung capacity for carbon
monoxide (DLCO) (preoperative and predicted post-
operative, in percentages), predicted postoperative
product, type of resection, lobe operated on, anesthesiaTable 1 Characteristics of the study population.a
Pneumonia group (n Z
Sex, male/female 21/1
Age, yrs 63  12
BMI, kg/m2 23.8  3.7
Weight loss >10 kgb 3 (13.6%)
Smoking, current and former 22 (100%)
Smoking (pack-years) 46  29
Alcohol abuse, current and former 5 (23%)
Alcohol, g/d 133  145
Co-morbidities
Chronic bronchitis 9 (40.9%)
COPD 16 (72.7%)
Classified COPD
Mild 1 (4.5%)
Moderate 8 (36.4%)
Severe 4 (18.2%)
Chronic heart disordersc 0 (0%)
Previous cancer 5 (22.7%)
BUN (mg/dL) 15  6
CEA (ng/mL) 12  16
Clinical TNM
T1N0M0 6 (27.3%)
T2N0M0 10 (45.5%)
T2N1M0 2 (9.1%)
T3N0M0 0 (0%)
T1N2M0 1 (4.5%)
T2N2M0 2 (9.1%)
T3N2M0 1 (4.5%)
Clinical stage
IA 6 (27.3%)
IB 10 (45.5%)
IIB 2 (9.1%)
IIIA 4 (18.2%)
Data are presented as number (%) or mean  standard deviation. Per
information. 50 patients had missing information on BUN and 57 miss
Abbreviations: BMI indicates body mass index; BUN, blood urea nitro
pulmonary disease; TNM, tumor-lymphatic nodes-metastasis.
a The Pneumonia Group shows patients with postoperative pneumo
operative pneumonia.
b Weight loss from the onset of symptoms to hospital admission.
c Chronic heart disorders include coronary artery disease, hyperten
any cause.time (Table 2), pain measured on the visual-analog scale
(VAS), and reintubation (Table 3).Characteristics of episodes of pneumonia
In the pneumonia group, the performed procedures were
pneumonectomy in 10 patients (45.5%), lobectomy in 9
patients (40.9%), bilobectomy in 2 patients (9.1%) (1 upper
and middle, and 1 middle and lower), and segmentectomy
in 1 patient (4.5%). The right hemithorax was involved in 14
patients (63.6%) and the left one in 8 (36.4%).
Postoperative nosocomial pneumonia appeared at 4  3
postoperative days. 15 patients had early nosocomial
pneumonia.22) Non-pneumonia group (n Z 62) p
58/4 0.75
65  10 0.31
26.7  3.6 0.002
2 (3.3%) 0.086
59 (95%) 0.70
58  47 0.28
7 (11%) 0.34
87  59 0.50
19 (30.6%) 0.38
48 (77.4%) 0.66
0.14
8 (12.9%)
19 (30.6%)
3 (4.8%)
10 (16.1%) 0.045
16 (25.8%) 0.77
19  5 0.041
5  3 0.036
0.041
16 (25.8%)
40 (64.5%)
4 (6.5%)
2 (3.2%)
0 (0%)
0 (0%)
0 (0%)
0.006
16 (25.8%)
40 (64.5%)
6 (9.7%)
0 (0%)
centages were based on the number of patients with non-missing
ing on CEA.
gen; CEA, carcinoembryonic antigen; COPD, chronic obstructive
nia and the Non-Pneumonia Group shows patients without post-
sive or valvular heart diseases, and dilated myocardial disease of
Table 2 Characteristics of the anesthesia and surgery.
Pneumonia group (n Z 22) Non-pneumonia group (n Z 62) p
Preoperative FEV1/FVC index 64  12 72  13 0.014
Preoperative FEV1, % 66  19 77  17 0.012
Preoperative FVC, % 79  12 83  14 0.28
Preoperative DLCO, % 66  17 79  17 0.006
Predicted postoperative FEV1, % 41  10 55  15 0.003
Predicted postoperative DLCO, % 45  10 57  12 0.004
Predicted postoperative product 1.9  0.5 2.9  1 0.003
Perfusion scintigraphy in operated hemithorax, % 48  9 48  9 0.99
Type of resection 0.017
Lobe-segment 13 (59.1%) 52 (83.9%)
Pneumonectomy 9 (40.9%) 10 (16.1%)
Duration of anesthesia, min 265  58 241  39 0.047
Duration of surgery, min 189  67 171  44 0.16
Data are presented as number (%) or mean  standard deviation. Percentages were based on the number of patients with non-missing
information. 45 patients had missing information on predicted postoperative product (PPP).
Abbreviations: DLCO indicates diffusion lung capacity for carbon monoxide; FEV1, forced expiratory volume in the first second; FVC,
forced vital capacity.
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(15 patients, 68.2%). Three patients (13.6%) suffered from
parapneumonic pleural effusion on the same hemithorax of
the infiltrate, with no evidence of empyema.
We isolated PPM in 10 cases (45.5%): P. aeruginosa (3),
Escherichia coli (2), Streptococcus pneumoniae (2), Hae-
mophilus influenzae (2), and S. aureus (1); whereas
etiology was not determined in the remaining 12 cases.
The prescribed antibiotics for the episodes of post-
operative pneumonia are shown in Table 4.Table 3 Characteristics of the postoperative period.
Pneumonia group (n Z
Pain (VAS) 3.8  1.3
Reintubation 10 (45.5%)
Need for vasoactive amines 8 (38.1%)
Postoperative arrhythmia 3 (13.6%)
Hemorrhage requiring transfusion 4 (18.2%)
Admission to ICU 18 (81.8%)
APACHE Classificationa 11.7  3.4
TI þ MV >24 h after surgery 7 (31.8%)
Stay in ICU, d 30  8
Fever >24 h after surgery 15 (75%)
Fiberoptic bronchoscopy 4 (18.2%)
Tracheostomy 2 (9.1%)
ARDS 3 (14.3%)
Septic shock 8 (36.4%)
Pleural effusion 3 (13.6%)
In-hospital mortality 7 (31.8%)
Mean stay in hospital, d 20.8  10.3
Data are presented as number (%) or mean  standard deviation. Per
information.
Abbreviations: APACHE indicates Acute Physiology and Chronic Hea
intensive care unit; TI þ MV, tracheal intubation and mechanical ven
a APACHE-II values are only calculated for patients admitted to theIn the postoperative period of the pneumonia group, 2
patients required reintubation at an early stage and 8 at
a late stage. In all of them, the cause of the reintubation
was respiratory insufficiency.
Two patients from the pneumonia group were intubated
and mechanically ventilated at the time of pneumonia
onset. Consequently, these 2 patients could be classified as
VAP patients. Their respective value of CPIS was 6 and 7.
The remaining patients were not intubated at the time of
pneumonia onset.22) Non-pneumonia group (n Z 62) p
2.9  1.5 0.046
1 (1.6%) <0.001
3 (4.8%) <0.001
2 (3.2%) 0.076
1 (1.6%) 0.005
19 (30.6%) <0.001
18.7  9.6 0.015
1 (1.6%) <0.001
3  4 0.035
7 (11.5%) <0.001
1 (1.6%) 0.005
0 (0%) 0.016
2 (3.2%) 0.066
0 (0%) <0.001
0 (0%) 0.003
3 (4.8%) 0.003
11.3  4.3 <0.001
centages were based on the number of patients with non-missing
lth Evaluation; ARDS, acute respiratory distress syndrome; ICU,
tilation; VAS, visual-analog scale.
ICU.
Table 4 Types of prescribed antibiotics.
Pneumonia
group (n Z 22)
Antipseudomonal cephalosporin and
quinolone
9
Antipseudomonal cephalosporin with
quinolone and glycopeptide
4
Antipseudomonal cephalosporin and
aminoglycoside
1
Cephalosporin and quinolone 1
Carbapenem and aminoglycoside 1
Carbapenem with aminoglycoside and
glycopeptide
1
Quinolone and macrolide 1
Quinolones with monobactam and
glycopeptides
1
Quinolone with carbapenem and
glycopeptides
1
Quinolone and carbapenem 1
Quinolone 1
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group pneumonia was 8 (4.5e16.5) days. In the non-
pneumonia group, there were only two reintubated
patients whose duration of mechanical intubation was 3
and 18 days, respectively.
Risk factors: univariate and multivariate analyses
(Table 5)
The statistically significant (p < 0.05) risk factors for
pneumonia in the univariate analysis were a lower BMI,
poorer predicted postoperative functional status (predicted
postoperative FEV1 % pred. and DLCO % pred.), pneumo-
nectomy as type of lung resection, reintubation, need forTable 5 Univariate and multivariate analysis of the relationshi
pneumonia.
Univariate analysis
OR 95% CI
VASa 1.56 0.99e2
BMI, kg/m2a 0.79 0.67e0
Predicted postoperative FEV1, %
a 0.92 0.86e0
Predicted postoperative DLCO, %a 0.91 0.85e0
Pneumonectomy vs. other resections 3.60 1.22e1
Duration of anesthesia, min 1.012 1.000e1
Reintubation 16.68 2.46e1
Need for vasoactive amines in the
postoperative period
12.10 2.82e5
Hemorrhage requiring transfusion 5.44 1.37e2
TI þ MV >24 h 28 3.196e2
Abbreviations: BMI indicates body mass index; DLCO, diffusion lung cap
first second; TI þ MV, tracheal intubation and mechanical ventilation
a Odds-ratio and 95% confidence interval of quantitative continuousvasoactive amines in the postoperative period, hemorrhage
requiring transfusion, and tracheal intubation and
mechanical ventilation (TI þ MV) >24 h.
The following factors appeared in the multivariate
analysis as statistically significant independent risk factors
for pneumonia, with a high predictive capacity: lower BMI
(OR 0.635, 95% CI 0.449e0.900, pZ 0.011) (<26.7 kg/m2 as
the best discriminating factor for the risk of postoperative
pneumonia, with AUC 0.79, sensitivity 58%, specificity 92%,
PLR 7.5, NLR 0.5), lower predicted postoperative FEV1 (OR
0.920, 95% CI 0.850e0.995, pZ 0.037) (<50.4% pred. as the
best discriminating factor, with AUC 0.79, sensitivity 48%,
specificity 100%, NRL 0.52), and reintubation (OR 18.1; 95%
CI 1.3e253.6, p Z 0.032; AUC 0.68, sensitivity 38%, speci-
ficity 100%, NLR 0.62).Mortality and clinical course of patients with
pneumonia: comparison of mortality of cases and
controls
The overall postoperative (in-hospital) mortality of patients
undergoing resection of lung carcinoma in the study period
was 5.3% (32 patients), whereas in-hospital mortality due to
postoperative pneumonia was 31.8% (7 cases). In 6 of the 7
cases, surgery involved pneumonectomy (4 of which were
right pneumonectomies).
The causes of death in these 7 cases were progression of
the pneumonia (3), multiorgan failure (3), and acute
respiratory distress syndrome (ARDS) (1).
The univariate analysis shows the variables that were
entered into the model. Statistically significant (p < 0.05)
risk factors for postoperative in-hospital mortality were
pneumonectomy as type of lung resection, reintubation,
need for postoperative vasoactive amines, TI þ MV >24 h,
and postoperative nosocomial pneumonia. Reintubation
was shown in the multivariate analysis as a statistically
significant independent risk factor for postoperative in-
hospital mortality (Table 6).p between association factors and postoperative nosocomial
Multivariate analysis
p OR 95% CI p
.46 0.054
.93 0.004 0.64 0.45e0.90 0.011
.98 0.008 0.92 0.85e0.99 0.037
.98 0.011
0.67 0.021
.024 0.057
13.05 0.004 18.1 1.3e253.6 0.032
1.93 0.001
1.63 0.016
45.31 0.003
acity for carbon monoxide; FEV1, forced expiratory volume in the
; VAS, visual-analog scale.
variables are given for units of measure.
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One of the main findings of this study is that the incidence of
postoperative pneumonia after lung resection was 3.6%. In
this population with pneumonia, the mortality was very high
(32%). The risk factors associated with the development of
pneumonia in the multivariate analysis were a lower BMI,
reintubation and lower predictive postoperative FEV1.
About the incidence of postoperative pneumonia after
lung resection, the literature ranges between 2% and
20%.5,6 These disparities may be explained by different
definitions of pneumonia, different diagnostic tests applied
and heterogeneity of populations between studies.1,2,4e7,11
The incidence reported by us (3.6%) fits with the results of
the literature in the low range of the incidence reported.
Literature regarding the comparison of the effectiveness
of different antibiotic regimens is limited.24 A recent
review concluded that existing evidence on what consti-
tutes the best and appropriate antibiotic prophylaxis in this
type of surgery is poor.1
In 45% of cases we could isolate a bacterial pathogen.
Interestingly, Gram negative bacilli were the principal
microorganisms. These results coincide with other from the
literature25 and reinforce our believe of broad initial anti-
microbial treatment, including Gram negative coverage,
when treating these pneumonias with antibiotics.
The overall mortality after resection of lung carcinoma
was 5%. However, in patients with pneumonia, it was very
high (32% vs. 5%). The findings of our study indicate that the
overall mortality reported is within expected values. For
example, in a national multicenter prospective study,
mortality reported in the first 30 days of hospitalization after
resection of bronchogenic carcinoma was 6.8%, with an
inter-hospital variation of 0%e11.6%. The high mortality
observed may have arisen because of the presence of
adverse risk factors (extensive comorbidity [84.4%] and
a high number of pneumonectomies [29.5%]), whereas the
high variability between hospitals may be because this was
a series with participants from different centers.14 In other
large studies,14 mortality after pulmonary resection was
2.5% but the rate of pneumonectomies was also lower
(6.5%). The only factor associated with higher mortality in
the overall population was reintubation and this coincides
with the results from Epstein et al.26 confirming that rein-
tubation is associated with an increased mortality in criti-
cally ill patients. Furthermore, according to a prospectiveTable 6 Univariate and multivariate analysis of the relationsh
mortality.
Univariate analysis
OR 95% CI
Pneumonectomy vs. other resections 12.056 2.725e53
Reintubation 94.667 13.703e65
Need for vasoactive amines in the
postoperative period
27.6 5.265e14
TI þ MV >24 h 23.333 4.285e12
Postoperative nosocomial pneumonia 9.178 2.118e39
Abbreviations: CI indicates confidence interval; OR, odds ratio; TI þstudy by Frutos-Vivar et al., reintubation was independently
associated with significantly higher mortality,26 due to the
development of complications following reintubation.
Mortality due to postoperative pneumonia reported in
the literature ranges between 22% and 67%. The mortality
of postoperative pneumonia reported by us agrees with
published ranges.
In our study the risk factors associated with the devel-
opment of pneumonia in the multivariate analysis were
a decreased BMI, reintubation, and lower predictive post-
operative FEV1.
A BMI value <26.5 kg/m2 had the best predictive
capacity for the development of pneumonia. A moderate
excess of weight, as we observed in this study, has also
been associated with decreased long-term mortality in
population-based studies.27
Given the significant findings of the multivariate model,
one could argue that a slightly elevated BMI (moderate over-
weight) has a protective effect for postoperative nosocomial
pneumonia after resection of bronchogenic carcinoma.
Therefore, optimizing nutritional status prior to surgerywould
improve the surgical outcome. Themoderate overweight may
be associated with improved postoperative survival during
adverse conditions such as infections or medical procedures,
and improved prognosis for some diseases. These findings
could be due to better nutritional reserves or to higher lean
body mass associated with moderate overweight.27
Reintubation was the main marker of risk of pneumonia
in our study. Years ago and using a case-control design, we
demonstrated that reintubation was a risk factor for VAP
development.28 Finally, pneumonia is one of the main
causes of postoperative mortality.
Another factor associated with risk of pneumonia was
a lower predicted FEV1 after surgery. Other studies are in
line with this finding, which is partially related to extent of
surgery.29 This finding reinforces the importance of preop-
erative lung function determinations in order to detect
patients at high risk of pneumonia.
Other risk factor described in the literature are age,
male sex, smoking habit, COPD, pain control, prolonged
duration of surgery and, previous bronchial colonization as
described in a previous study from our group.6
The importance of knowing the risk factors for pneu-
monia is the potential of preventing this important
complication. Some of the factors described above are
amenable to medical intervention. Interventions can beip between association factors and in-hospital postoperative
Multivariate analysis
p OR 95% CI p
.34 0.001
4 <0.001 81.667 11.61e574.36 <0.001
4.68 <0.001
7.05 <0.001
.78 0.003
MV, tracheal intubation and mechanical ventilation.
1470 V. Dı´az-Ravetllat et al.classified as those that could be undergone before surgery,
during surgery and after surgery. Our results and others
from the literature6 advise a careful screening of those
patients at a high risk (including bronchial colonization), an
optimal management during the intervention and
extremely careful management of patients after extuba-
tion doing all the efforts and precautions to avoid reintu-
bation and a careful management of pain.
A major limitation of our study is the defined sample
size, which is small to make a robust analysis of all related
questions. The sample-size calculation was based in the
percentage of patients reintubated, where a total sample
size of 88 patients (22 patients in pneumonia arm and 66
patients in non-pneumonia arm, according to 1:3 allocation
ratio) is large enough if the expected difference is 35%.
Larger studies are needed, which include the afore-
mentioned variables and determine statistically significant
variables that can guide future research with the objective
of reducing the incidence of mortality and postoperative
pneumonia.
In conclusion, we can state that a slightly elevated BMI
(slightly overweight) has a protective effect against
acquiring nosocomial pneumonia after resection of bron-
chogenic carcinoma. Therefore, optimization of the nutri-
tional status of patients prior to surgery, avoiding
reintubation, and trying to optimize the resection to
conserve the lung parenchyma as much as possible, may
lead to a decreased incidence of postoperative pneumonia.
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